Overview

Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress

Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the cardiovascular profiles of efavirenz and rilpivirine, which are two drugs used to treat HIV infection.
Phase:
Phase 4
Details
Lead Sponsor:
Indiana University
Collaborator:
Janssen Services, LLC
Treatments:
Efavirenz
Rilpivirine